WebApr 12, 2024 · The Board of Directors of Photocure ASA has approved the annual accounts for 2024. The financial statements and annual report for the financial year 2024 are together with the ESG report and auditor's report attached to this notice. The ESEF file for 2024 is also attached. The documents are enclosed and also made available at the company's ... WebMar 14, 2024 · Photocure is commercializing Cysview/Hexvix directly in the U.S. and Europe and has strategic partnerships for the commercialization of Hexvix/Cysview in China, Chile, Australia, New Zealand and ...
Photocure ASA: Results for the second quarter of 2024 - PR …
WebMay 11, 2024 · Oslo, Norway, 11 May 2024: Photocure ASA (OSE:PHO) today reported Hexvix®/Cysview® revenues of NOK 81.4 million in the first quarter of 2024 (Q1 2024: … WebFeb 7, 2024 · "The successful FDA approval is great news for the bladder cancer community in the U.S.," commented Geoffrey Coy, Vice President and General Manager, North America at Photocure. ios system storage high
Photocure ASA - Notice of the Annual General Meeting 3 …
WebApr 12, 2024 · Oslo, Norway, 12 April 2024: Photocure ASA (OSE: PHO), calls for the annual general meeting of Photocure ASA to be held on 3 May 2024 at 17:00 hours (CEST), virtual through the general meeting portal administered by Euronext Securities Oslo (the "Euronext Securities Portal"). The general meeting will be webcasted live and a link will be ... WebMar 21, 2024 · Oslo, Norway, March 21, 2024 – Photocure ASA (OSE: PHO), The Bladder Cancer Company, announces Karl Storz’s continued commitment to blue light cystoscopy with plans to maximize the ongoing rollout of its new high-definition rigid blue light cystoscopy (BLC ®) system, Saphira™.Due to previously disclosed component supply … WebSubscribe to our newsfeed and be kept up to date with the latest Photocure company news. Sign up now. GLOBAL HEADQUARTERS. Photocure ASA Hoffsveien 4 0275 Oslo Norway. … ontological coaching institute